Francesca L. Mordant
ORCID: 0000-0002-3754-2642Also affiliated with Peter Doherty Institute
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 5 papers. Top paper: “Safety and immunogenicity of an MF59-adjuvanted spike glycoprotein-clamp vaccine for SARS-CoV-2: a randomised, double-blind, placebo-controlled, phase 1 trial”.
Francesca L. Mordant, Zheyi Li, Danushka K. Wijesundara, Paula Ellenberg, Julia Lackenby +30 more
Natasha E. Holmes, Francesca L. Mordant, Celia Douros, Sara E. Zufan, Thi H. O. Nguyen +11 more
Łukasz Kedzierski, Brendon Y. Chua, Mark Mayo, Claire Lonzi, Vanessa Rigas +41 more
Louise C. Rowntree, Lilith F. Allen, Brendon Y. Chua, Łukasz Kedzierski, Chhay Lim +50 more
Emily M. Eriksson, Peta Edler, Francesca L. Mordant, Nicholas Kiernan‐Walker, David J. Price +10 more